FDA advisers to vote on omicron-targeted fall Covid-19 boosters.
The FDA advisory committee will vote on the composition of updated Covid-19 vaccines that are expected to roll out in the fall, with available evidence suggesting that the new vaccine should protect against just one strain of the SARS-CoV-2 virus and should target one of three that are currently circulating in the US. The FDA appears set to follow international guidance and remove the ancestral spike in future vaccines, which would keep it in step with the World Health Organization's advisory group's recommendation. Vaccine manufacturers Pfizer, Moderna, and Novavax have been working on updated versions of the vaccines, even manufacturing them in advance, and are each scheduled to present at the FDA advisory meeting.
- FDA advisers to vote on composition of fall Covid-19 boosters CNN
- FDA advisers to vote on COVID-19 vaccines WFAA
- FDA advisers consider changing COVID vaccine to target latest omicron strain The Associated Press
- FDA advisers to vote fall COVID-19 boosters CBS Philadelphia
- The strain COVID vaccines might target next Axios
Reading Insights
0
0
4 min
vs 5 min read
88%
985 → 114 words
Want the full story? Read the original article
Read on CNN